Custom Peptide Batch (Custom (10mg–5g))
Bespoke Solid-Phase Peptide Synthesis (SPPS) from milligram to multi-gram scales supporting N-terminal acetylation, C-terminal amidation, D-amino acid substitution, disulfide cyclization, fluorescent tagging, and acetate/HCl counterion exchange.
Scientific Profile & Research Key Points: Custom Peptide Batch
Bespoke Solid-Phase Peptide Synthesis (SPPS) from milligram to multi-gram scales supporting N-terminal acetylation, C-terminal amidation, D-amino acid substitution, disulfide cyclization, fluorescent tagging, and acetate/HCl counterion exchange.
Active Batch Release Specifications (Lot SL-2026-119)
Analytical release verification for current Custom Peptide Batch (Custom (10mg–5g)) inventory
| Batch Lot # | Release Date | Analytical Method | Purity Spec | Endotoxin (LAL) | Moisture |
|---|---|---|---|---|---|
| SL-2026-119 | 2026-10-28 | RP-HPLC (C18, 214nm) + ESI-MS | ≥99.0% (Single Peak) | <0.5 EU/mg | <2.8% (Karl Fischer) |
Laboratory Solubilization & Storage Protocol
Recommended Solvent / Handling
Custom solubility profiling provided with batch CoA
Temperature & Stability
Lyophilized under nitrogen purge at -20°C; custom aliquoting available.
Custom Peptide Batch — Technical Questions & Answers
What sequence lengths and modifications are supported for custom SPPS orders?
Automated Fmoc solid-phase synthesis supports sequences from 4 to 70+ residues, including N-terminal acetylation, C-terminal amidation, D-amino acid substitutions, PEGylation, biotinylation, and intramolecular disulfide cyclization.
Can custom batches be delivered with acetate instead of TFA counterions?
Yes. Residual trifluoroacetate (TFA) can interfere with sensitive cell-culture viability assays; optional ion-exchange conversion to acetate or HCl salt is available on request with analytical release documentation.
What analytical deliverables accompany each custom synthesis batch?
Every custom lot includes sequence-specific RP-HPLC chromatogram verification (≥98% or ≥99% grade), ESI-MS monoisotopic mass confirmation within ±0.1 Da, and Karl Fischer moisture release specs.
Related Scientific Monographs
Peer-reviewed mechanism summaries and analytical protocols
How to Verify a Peptide COA (2026): RP-HPLC Purity vs. ESI-MS Identity, Quantitative Fill & Fake Report Red Flags
Step-by-step analytical audit guide for laboratory buyers: why RP-HPLC purity alone does not prove sequence identity or vial milligram fill, plus how to detect altered or recycled COAs.
Evaluating European & Swiss Research Peptide Suppliers (2026): Intra-EU Customs, UK Post-Closure Shifts & Cold-Chain GDP
How European laboratories audit peptide suppliers in 2026 after UK storefront closures and overseas customs bottlenecks: entity transparency, batch traceability, SEPA settlement, and cold-chain dispatch.
Switzerland vs. EU Laboratory Peptide Logistics: FOCBS Customs Boundaries, Swissmedic RUO Governance & Thermal Stability
Why Switzerland's non-EU customs boundary affects laboratory peptide shipping: FOCBS border clearance, Swissmedic Research Use Only (RUO) governance, and cold-chain thermal kinetics.